Last reviewed · How we verify
NCT05824104
Exploratory Study of Intermittent Hypoxia Treatment in Chronic Cerebral Hypoperfusion
NA trial testing Intermittent Hypoxia in Chronic Cerebral Hypoperfusion in 20 participants. Status unknown.
10 September 2023
Quick facts
| Lead sponsor | Capital Medical University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 20 |
| Start date | 10 May 2023 |
| Primary completion | 10 September 2023 |
| Estimated completion | 10 October 2023 |
Drugs / interventions tested
- Intermittent Hypoxia
Conditions studied
- Chronic Cerebral Hypoperfusion — all drugs for Chronic Cerebral Hypoperfusion →
Sponsor
Capital Medical University
Who can join
Adults 45 to 70, any sex, with Chronic Cerebral Hypoperfusion. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to investigate the safety and efficacy of intermittent hypoxia treatment in patients with chronic cerebral hypoperfusion.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05824104
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Intermittent Hypoxia
Trials testing the same drug.
- NCT07394699 — Efficiency of Intermittent Hypoxia Intervention in Primary Insomnia · NA · not yet recruiting
- NCT05733338 — The Effects of Intermittent Hypoxia on Acute Hypoxic Injury · NA · unknown
- NCT05463042 — Intermittent Hypoxia and Balance Control · NA · completed
- NCT04280484 — Acute Intermittent Hypoxia in Persons With Multiple Sclerosis · NA · completed
- NCT03029559 — Intermittent Hypoxia and Inspiratory Threshold Loading to Enhance Inspiratory Muscle Function · NA · completed
Other Capital Medical University trials
Trials by the same sponsor.
- NCT07379437 — Haematococcus Pluvialis Astaxanthin for Brain Aging · NA · not yet recruiting
- NCT07531394 — Safety and Efficacy of Remote Ischemic Conditioning in Patients With Acute Myocardial Injury Following Acute Ischemic St · Phase 3 · not yet recruiting
- NCT07509645 — Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Post · Phase 3 · recruiting
- NCT07513233 — Anisodine Hydrobromide for Patients With Acute Ischemic Stroke Undergoing Endovascular Therapy (HEAL) · Phase 1 · not yet recruiting
- NCT07495358 — Development and Usability Evaluation of a Knowledge Graph-Based Symptom Management System for Patients With Breast Cance · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05824104 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Capital Medical University
- Last refreshed: 25 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05824104.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing